secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001140361-25-030853
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Skin Sciences Q2 revenue down 9% to $7.7M; net loss widens to $2.5M, EPS -$0.60
--------------------------------------------------------------------------------

- Revenue $7.7M (down 9% YoY); net loss $2.5M vs $0.1M loss in Q2 2024 (EPS -$0.60 vs -$0.03).
- Gross profit $4.3M (56% of revenue) vs $5.0M in prior year.
- Cash at June 30 $6.0M; nearly operating cash flow breakeven when adjusted for $1.3M NY tax payment and ~$340k legal costs.
- CPT code expansion triples covered patient population; G-code application filed for accelerated 2026 reimbursement.
- Removed 21 XTRAC devices, placed 19 (highest in six quarters); lawsuit against LaserOptek adds defendants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125030853/0001140361-25-030853-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125030853/ef20053890_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-030853

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer